Abstract
The largest energy consumer in the cell is the ribosome biogenesis whose aberrancy elicits various diseases in humans. It has been recently revealed that p53 induction, along with cell cycle arrest, is related with abnormal ribosome biogenesis, but the exact mechanism still remains unknown. In this study, we have found that aberrant ribosome biogenesis activates two parallel cellular pathways, c-Myc and ASK1/p38, which result in p53 induction and G1 arrest. The c-Myc stabilizes p53 by rpL11-mediated HDM2 inhibition, and ASK1/p38 activates p53 by phosphorylation on serine 15 and 33. Our studies demonstrate the relationship between these two pathways and p53 induction. The changes caused by impaired ribosomal stress, such as p53 induction and G1 arrest, were completely disappeared by inhibition of either pathway. These findings suggest a monitoring mechanism of c-Myc and ASK1/p38 against abnormal ribosome biogenesis through controlling the stability and activity of p53 protein.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Amsterdam A, Sadler KC, Lai K, Farrington S, Bronson RT, Lees JA et al. (2004). Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol 2: E139.
Anderson SJ, Lauritsen JP, Hartman MG, Foushee AM, Lefebvre JM, Shinton SA et al. (2007). Ablation of ribosomal protein L22 selectively impairs alphabeta T cell development by activation of a p53-dependent checkpoint. Immunity 26: 759–772.
Barna M, Pusic A, Zollo O, Costa M, Kondrashov N, Rego E et al. (2008). Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Nature 456: 971–975.
Belin S, Beghin A, Solano-Gonzalez E, Bezin L, Brunet-Manquat S, Textoris J et al. (2009). Dysregulation of ribosome biogenesis and translational capacity is associated with tumor progression of human breast cancer cells. PLoS One 4: e7147.
Bode AM, Dong Z . (2004). Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer 4: 793–805.
Boisvert FM, van Koningsbruggen S, Navascues J, Lamond AI . (2007). The multifunctional nucleolus. Nat Rev Mol Cell Biol 8: 574–585.
Bulavin DV, Saito S, Hollander MC, Sakaguchi K, Anderson CW, Appella E et al. (1999). Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J 18: 6845–6854.
Cazzaniga G, Dell′Oro MG, Mecucci C, Giarin E, Masetti R, Rossi V et al. (2005). Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype. Blood 106: 1419–1422.
Cleveland JL, Sherr CJ . (2004). Antagonism of Myc functions by Arf. Cancer Cell 6: 309–311.
Dai MS, Lu H . (2008). Crosstalk between c-Myc and ribosome in ribosomal biogenesis and cancer. J Cell Biochem 105: 670–677.
Dai MS, Sears R, Lu H . (2007). Feedback regulation of c-Myc by ribosomal protein L11. Cell Cycle 6: 2735–2741.
Ellis SR, Lipton JM . (2008). Diamond Blackfan anemia: a disorder of red blood cell development. Curr Top Dev Biol 82: 217–241.
Fromont-Racine M, Senger B, Saveanu C, Fasiolo F . (2003). Ribosome assembly in eukaryotes. Gene 313: 17–42.
Fumagalli S, Di Cara A, Neb-Gulati A, Natt F, Schwemberger S, Hall J et al. (2009). Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction. Nat Cell Biol 11: 501–508.
Gazda HT, Sheen MR, Vlachos A, Choesmel V, O′Donohue MF, Schneider H et al. (2008). Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients. Am J Hum Genet 83: 769–780.
Giono LE, Manfredi JJ . (2006). The p53 tumor suppressor participates in multiple cell cycle checkpoints. J Cell Physiol 209: 13–20.
Granneman S, Baserga SJ . (2004). Ribosome biogenesis: of knobs and RNA processing. Exp Cell Res 296: 43–50.
Ho JS, Ma W, Mao DY, Benchimol S . (2005). p53-dependent transcriptional repression of c-myc is required for G1 cell cycle arrest. Mol Cell Biol 25: 7423–7431.
Idol RA, Robledo S, Du HY, Crimmins DL, Wilson DB, Ladenson JH et al. (2007). Cells depleted for RPS19, a protein associated with Diamond Blackfan Anemia, show defects in 18S ribosomal RNA synthesis and small ribosomal subunit production. Blood Cells Mol Dis 39: 35–43.
Iordanov MS, Pribnow D, Magun JL, Dinh TH, Pearson JA, Chen SL et al. (1997). Ribotoxic stress response: activation of the stress-activated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the alpha-sarcin/ricin loop in the 28S rRNA. Mol Cell Biol 17: 3373–3381.
Kim HD, Kim TS, Joo YJ, Shin HS, Kim SH, Jang CY et al. (2010). RpS3 translation is repressed by interaction with its own mRNA. J Cell Biochem 110: 294–303.
Kim TS, Jang CY, Kim HD, Lee JY, Ahn BY, Kim J . (2006). Interaction of Hsp90 with ribosomal proteins protects from ubiquitination and proteasome-dependent degradation. Mol Biol Cell 17: 824–833.
Kim TS, Kim HD, Kim J . (2009). PKCdelta-dependent functional switch of rpS3 between translation and DNA repair. Biochim Biophys Acta 1793: 395–405.
Kishi H, Nakagawa K, Matsumoto M, Suga M, Ando M, Taya Y et al. (2001). Osmotic shock induces G1 arrest through p53 phosphorylation at Ser33 by activated p38MAPK without phosphorylation at Ser15 and Ser20. J Biol Chem 276: 39115–39122.
Laskin JD, Heck DE, Laskin DL . (2002). The ribotoxic stress response as a potential mechanism for MAP kinase activation in xenobiotic toxicity. Toxicol Sci 69: 289–291.
Lavin MF, Gueven N . (2006). The complexity of p53 stabilization and activation. Cell Death Differ 13: 941–950.
Liu JM, Ellis SR . (2006). Ribosomes and marrow failure: coincidental association or molecular paradigm? Blood 107: 4583–4588.
Macias E, Jin A, Deisenroth C, Bhat K, Mao H, Lindstrom MS et al. (2010). An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction. Cancer Cell 18: 231–243.
Maggi Jr LB, Weber JD . (2005). Nucleolar adaptation in human cancer. Cancer Invest 23: 599–608.
Menne TF, Goyenechea B, Sanchez-Puig N, Wong CC, Tonkin LM, Ancliff PJ et al. (2007). The Shwachman-Bodian-Diamond syndrome protein mediates translational activation of ribosomes in yeast. Nat Genet 39: 486–495.
Ofir-Rosenfeld Y, Boggs K, Michael D, Kastan MB, Oren M . (2008). Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26. Mol Cell 32: 180–189.
Oliver ER, Saunders TL, Tarle SA, Glaser T . (2004). Ribosomal protein L24 defect in belly spot and tail (Bst), a mouse minute. Development 131: 3907–3920.
Opferman JT, Zambetti GP . (2006). Translational research? ribosome integrity and a new p53 tumor suppressor checkpoint. Cell Death Differ 13: 898–901.
Pestov DG, Strezoska Z, Lau LF . (2001). Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S transition. Mol Cell Biol 21: 4246–4255.
Robledo S, Idol RA, Crimmins DL, Ladenson JH, Mason PJ, Bessler M . (2008). The role of human ribosomal proteins in the maturation of rRNA and ribosome production. RNA 14: 1918–1929.
Ruggero D, Pandolfi PP . (2003). Does the ribosome translate cancer? Nat Rev Cancer 3: 179–192.
Sherr CJ . (2006). Divorcing ARF and p53: an unsettled case. Nat Rev Cancer 6: 663–673.
Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S et al. (1998). The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J 17: 5001–5014.
Sulic S, Panic L, Barkic M, Mercep M, Uzelac M, Volarevic S . (2005). Inactivation of S6 ribosomal protein gene in T lymphocytes activates a p53-dependent checkpoint response. Genes Dev 19: 3070–3082.
Sumbayev VV, Yasinska IM . (2005). Regulation of MAP kinase-dependent apoptotic pathway: implication of reactive oxygen and nitrogen species. Arch Biochem Biophys 436: 406–412.
Sundqvist A, Liu G, Mirsaliotis A, Xirodimas DP . (2009). Regulation of nucleolar signalling to p53 through NEDDylation of L11. EMBO Rep 10: 1132–1139.
Takagi M, Absalon MJ, McLure KG, Kastan MB . (2005). Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell 123: 49–63.
Ullrich SJ, Anderson CW, Mercer WE, Appella E . (1992). The p53 tumor suppressor protein, a modulator of cell proliferation. J Biol Chem 267: 15259–15262.
Zhang Y, Lu H . (2009). Signaling to p53: ribosomal proteins find their way. Cancer Cell 16: 369–377.
Zimmermann RA . (2003). The double life of ribosomal proteins. Cell 115: 130–132.
Acknowledgements
We thank Professor E-J Choi (Korea University, Seoul, Korea) for the kind gifts of ASK1 antibody and GST-MKK6 protein. This work was supported in part by FPR08B1-230, 2008-0059301 and 2009-0086319 NRF Grants from Ministry of Education and Science of Korea.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Supplementary information
Rights and permissions
About this article
Cite this article
Kim, H., Kim, TS. & Kim, J. Aberrant ribosome biogenesis activates c-Myc and ASK1 pathways resulting in p53-dependent G1 arrest. Oncogene 30, 3317–3327 (2011). https://doi.org/10.1038/onc.2011.47
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2011.47
Keywords
This article is cited by
-
RNA-Seq based transcriptome analysis in oral lichen planus
Hereditas (2021)
-
Ribosomal protein S3 selectively affects colon cancer growth by modulating the levels of p53 and lactate dehydrogenase
Molecular Biology Reports (2020)
-
5-Fluorouracil signaling through a calcium–calmodulin-dependent pathway is required for p53 activation and apoptosis in colon carcinoma cells
Oncogene (2013)